Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Framycetin | Framycetin (Neomycin B), an aminoglycoside antibiotic, is a potent RNase P cleavage activity inhibitor with a K i of 35 μM. Framycetin competes for specific divalent metal ion binding sites in RNase P RNA. Framycetin inhibits hammerhead ribozyme with a K i of 13.5 μM. Framycetin, a 5"-azido neomycin B precursor, binds the Drosha site in miR-525 and is used for hepatic encephalopathy and enteropathogenic E. coli infections [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Neomycin B; Fradiomycin B. CAS No. 119-04-0. Pack Sizes: 25 mg (16.27 mM * 2.5 mL in 0.9% NaCl); 50 mg (16.27 mM * 5 mL in 0.9% NaCl); 100 mg (16.27 mM * 10 mL in 0.9% NaCl). Product ID: HY-17624. |  |
| Framycetin sulfate | 100mg Pack Size. Group: Antibiotics, Bioactive Small Molecules, Research Organics & Inorganics. Formula: C23H46N6O13. CAS No. 4146-30-9. Prepack ID 51732338-100mg. Molecular Weight 712.72. See USA prepack pricing. |  |
| Framycetin sulfate | Framycetin sulfate (Neomycin B sulfate), an aminoglycoside antibiotic, is a potent RNase P cleavage activity inhibitor with a K i of 35 μM. Framycetin sulfate competes for specific divalent metal ion binding sites in RNase P RNA. Framycetin sulfate inhibits hammerhead ribozyme with a K i of 13.5 μM. Framycetin sulfate, a 5"-azido neomycin B precursor, binds the Drosha site in miR-525 and is used for hepatic encephalopathy and enteropathogenic E. coli infections [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Neomycin B sulfate; Fradiomycin B sulfate. CAS No. 4146-30-9. Pack Sizes: 25 mg; 50 mg; 100 mg. Product ID: HY-17624A. | |
| Neamine | Neamine, also known as Neomycin A, is a broad-spectrum aminoglycoside antibiotic derived from the neomycin complex produced by the actinomycete S. fradiae. It is a degradation product of neomycin and has potent antibacterial, antitumor, and neuroprotective activities. Neamine is an anti-angiogenesis agent that targets angiogenin and has been shown to inhibit ANG-mediated AsPC-1 cell proliferation in a dose-dependent manner in vitro. In vivo, Neamine has demonstrated anti-tumor effects on AsPC-1 xenograft models, reducing the expression levels of ANG, Ki-67, and CD31 in tumor xenografts. Synonyms: Neomycin Sulfate EP Impurity A; 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-D-streptamine; Framycetin Sulfate EP Impurity A; Neomycin B sulfate EP Impurity A; Negamicin; Dekamycin V; Neomycin A; 4-O-(2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine; (+)-Neamine; Neamin; Nebramycin X; O-2,6-Diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)-1,3-diamino-1,2,3-trideoxy-D-myo-inositol; ST 7 (neomycin A); Neomycin Impurity A. Grade: >95%. CAS No. 3947-65-7. Molecular formula: C12H26N4O6. Mole weight: 322.36. |  |
| Neomycin B | Neomycin B is originally isolated from Str. fradiae 3535. It is mainly resistant to bacteria and mycobacteria, and its activity is the strongest of the three components. Synonyms: Framycetin; Mycifradin; Soframycin; O-2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→3)-O-β-D-ribofuranosyl-(1→5)-O-[2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)]-2-deoxy-D-streptamine; Actilin; Actiline; Antibiotic 10676; Antibiotique EF 185; Dekamycin III; Enterfram; Fradiomycin B; Framidal; Framycin; Framygen; Francetin; Fraquinol; Leo Red Dry Cow. Grade: ≥95%. CAS No. 119-04-0. Molecular formula: C23H46N6O13. Mole weight: 614.64. | |
| Neomycin B Sulfate | Neomycin B Sulfate is the sulfate salt form of Neomycin B, an aminoglycoside antibiotic. Synonyms: O-2,6-Diamino-2,6-dideoxy-β-L-idopyranosyl-(1→3)-O-β-D-ribofuranosyl-(1→5)-O-[2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)]-2-deoxy-D-streptamine Sulfate (1:1); Framycetin Sulphate; D-Streptamine, O-2,6-diamino-2,6-dideoxy-β-L-idopyranosyl-(1→3)-O-β-D-ribofuranosyl-(1→5)-O-[2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)]-2-deoxy-, sulfate (1:1); Neomycin B monosulfate; D-Streptamine, O-2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)-O-[O-2,6-diamino-2,6-dideoxy-β-L-idopyranosyl-(1→3)-β-D-ribofuranosyl-(1→5)]-2-deoxy-, sulfate (1:1) (salt); Neomycin B, sulfate (1:1) (salt); NSC 156885. Grade: ≥95%. CAS No. 25389-98-4. Molecular formula: C23H46N6O13.H2O4S. Mole weight: 712.72. | |
| Neomycin C | Neomycin C is originally isolated from Str. fradiae 3535. It is mainly resistant to bacteria and mycobacteria. Synonyms: Neomycin Sulfate EP Impurity C; Neomycin Impurity C; Framycetin Sulfate EP Impurity C; Neomycin B sulfate EP Impurity C; 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-β-D-ribofuranosyl]-D-streptamine; O-2,6-Diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)-O-[O-2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→3)-β-D-ribofuranosyl-(1→5)]-2-deoxy-D-streptamine; O-2,6-Diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→3)-O-β-D-ribofuranosyl-(1→5)-O-[2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)]-2-deoxy-D-streptamine; Dekamycin II. Grade: 99%. CAS No. 66-86-4. Molecular formula: C23H46N6O13. Mole weight: 614.64. | |
| Neomycin sulfate | Neomycin sulfate is an aminoglycoside antibiotic. It can be used to prevent and treat gastrointestinal infections caused by gram-negative bacteria such as Salmonella and Escherichia coli, such as Salmonella infection in pigs and chickens, E. coli disease, chicken paratyphoid, staphylococcal disease, necrotizing enteritis, fowl cholera, etc. Uses: Anti-bacterial agents. Synonyms: Framycetin Sulfate; Neomycin B Sulfate; Neomycin, sulfate (salt); Biosol; Bykomycin; Endomixin; Fradiomycin sulfate; Lidamycin Creme; Myacine; Mycerin sulfate; Mycifradin; Mycifradin N; Myciguent; Neo-Mantle Creme; Neo-rx; Neobrettin; Neofracin; Neolate; Neomix; Neomycin sulphate; Neosulf; New France F; Nivemycin; Otobiotic; Quintess-N; Tuttomycin. Grade: >98%. CAS No. 1405-10-3. | |
| Neomycin trisulfate | Neomycin trisulfate is an aminoglycoside antibiotic. It can be used to prevent and treat gastrointestinal infections caused by gram-negative bacteria such as Salmonella and Escherichia coli. Synonyms: (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol trisulfate; Framycetin sulfate; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-b-L-idopyranosyl)-b-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-a-D-glucopyranoside trisulfate salt. CAS No. 879480-48-5. Molecular formula: C23H46N6O13.3H2SO4. Mole weight: 908.88. | |
| Paromomycin | It is produced by the strain of Streptomyces rimosus var. paromomycinus. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. It has a role as an antibacterial drug, an antiprotozoal drug, an anthelminthic drug and an antiparasitic agent. Synonyms: Neomycin Sulfate EP Impurity E; Neomycin Impurity E; Framycetin Sulfate EP Impurity E; Neomycin B sulfate EP Impurity E; Catenulin; Aminosidin; Hydroxymycin; Zygomycin A1; Crestomycin; Paucimycin; Estomycin; Monomycin A; Paromomycin I; O-2,6-Diamino-2,6-dideoxy-β-L-idopyranosyl-(1→3)-O-β-D-ribofuranosyl-(1→5)-O-[2-amino-2-deoxy-α-D-glucopyranosyl-(1→4)]-2-deoxy-D-streptamine; Zygomycin A; Aminosidine; Aminosidine I; Amminosidin; Antibiotic 2230D; Antibiotic 503-3; Antibiotic SF 767B; Gabbromicina; Gabbromycin; Gabromycin; Humycin; Neomycin E; Paromomycin; Paromomycine; Quintomycin C; R 400. Grade: ≥95%. CAS No. 7542-37-2. Molecular formula: C23H45N5O14. Mole weight: 615.63. | |
| Paromomycin II | It is produced by the strain of Str. rimosus forma paromomycinus NRRL 2455. It's an aminoglycoside antibiotic. It has activity against gram-positive, negative bacteria, mycobacterium and protozoa. It has good curative effect for amebic dysentery and a few bacillary dysentery. Synonyms: Neomycin Sulfate EP Impurity F; Neomycin Impurity F; Framycetin sulfate EP Impurity F; Neomycin B sulfate EP Impurity F; 4-O-(2-Amino-2-deoxy-α-D-glucopyranosyl)-2-deoxy-5-O-[3-O-(2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl)-β-D-ribofuranosyl]-D-streptamine; Neomycin F; O-2-Amino-2-deoxy-α-D-glucopyranosyl-(1→4)-O-[O-2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→3)-β-D-ribofuranosyl-(1→5)]-2-deoxy-D-streptamine; O-2,6-Diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→3)-O-β-D-ribofuranosyl-(1→5)-O-[2-amino-2-deoxy-α-D-glucopyranosyl-(1→4)]-2-deoxy-D-streptamine; Paromomycin II; Aminosidin II; Aminosidine II; Zygomycin A2. Grade: ≥95%. CAS No. 51795-47-2. Molecular formula: C23H45N5O14. Mole weight: 615.63. | |
Our database is helping our users find suppliers everyday.
